Saturday, October 31, 2026

Marathon Stock Is 26% Up In The Last 10 Sessions

Marathon Stock Is 26% Up In The Last 10 Sessions

(VIANEWS) - Shares of Marathon (NASDAQ: MARA) rose by a staggering 26.65% in 10 sessions from $9.38 at 2023-06-09, to $11.88 at 14:23 EST on Monday, following the last session's upward trend. NASDAQ is dropping 0.83% to $13,380.60, following the last session's downward trend.

Marathon's last close was $12.71, 32.68% under its 52-week high of $18.88.

About Marathon

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-6.48.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -103.2%.

Volume

Today's last reported volume for Marathon is 44665606 which is 23.48% above its average volume of 35881900.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon's stock is considered to be oversold (<=20).

Sales Growth

Marathon's sales growth is 274.8% for the current quarter and 926.5% for the next.

Yearly Top and Bottom Value

Marathon's stock is valued at $11.88 at 14:23 EST, way below its 52-week high of $18.88 and way above its 52-week low of $3.11.

More news about Marathon (MARA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com